Medical Care
Global Precision Medicine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 16, 25
- ID: 189255
- Pages: 106
- Figures: 104
- Views: 1
The global Precision Medicine market size was US$ 142800 million in 2024 and is forecast to a readjusted size of US$ 268890 million by 2031 with a CAGR of 9.6% during the forecast period 2025-2031.
According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.
The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics is about 67%.
Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the market share is about 30%.
Market competition is intense. Johnson & Johnson, Roche, Labcorp, Abbott Laboratories and Novartis are the leaders of the industry, with about 56% market shares.
The global Precision Medicine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Johnson & Johnson
Roche
Labcorp
Abbott Laboratories
Novartis
Illumina
GE Healthcare
Intel Corporation
Biomrieux Sa
Cepheid
IBM
Qiagen
Thermo Fisher Scientific
Randox Laboratories
Almac Group
Healthcore
By Type: (Dominant Segment vs High-Margin Innovation)
Diagnostics
Therapies
By Application: (Core Demand Driver vs Emerging Opportunity)
Oncology
Neurosciences
Immunology
Respiratory
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Johnson & Johnson in Europe)
- Emerging Product Trends: Diagnostics adoption vs. Therapies premiumization
- Demand-Side Dynamics: Oncology growth in China vs. Neurosciences potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Precision Medicine market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Therapies in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Neurosciences in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Precision Medicine value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.
The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics is about 67%.
Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the market share is about 30%.
Market competition is intense. Johnson & Johnson, Roche, Labcorp, Abbott Laboratories and Novartis are the leaders of the industry, with about 56% market shares.
The global Precision Medicine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Johnson & Johnson
Roche
Labcorp
Abbott Laboratories
Novartis
Illumina
GE Healthcare
Intel Corporation
Biomrieux Sa
Cepheid
IBM
Qiagen
Thermo Fisher Scientific
Randox Laboratories
Almac Group
Healthcore
By Type: (Dominant Segment vs High-Margin Innovation)
Diagnostics
Therapies
By Application: (Core Demand Driver vs Emerging Opportunity)
Oncology
Neurosciences
Immunology
Respiratory
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Johnson & Johnson in Europe)
- Emerging Product Trends: Diagnostics adoption vs. Therapies premiumization
- Demand-Side Dynamics: Oncology growth in China vs. Neurosciences potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Precision Medicine market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Therapies in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Neurosciences in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Precision Medicine value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostics
1.2.3 Therapies
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Medicine Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Precision Medicine Revenue Market Share by Region (2020-2025)
2.4 Global Precision Medicine Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Precision Medicine Market Size and Prospective (2020-2031)
2.5.2 Europe Precision Medicine Market Size and Prospective (2020-2031)
2.5.3 China Precision Medicine Market Size and Prospective (2020-2031)
2.5.4 Japan Precision Medicine Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Precision Medicine Historic Market Size by Type (2020-2025)
3.2 Global Precision Medicine Forecasted Market Size by Type (2026-2031)
3.3 Different Types Precision Medicine Representative Players
4 Breakdown Data by Application
4.1 Global Precision Medicine Historic Market Size by Application (2020-2025)
4.2 Global Precision Medicine Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Precision Medicine Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Precision Medicine Players by Revenue (2020-2025)
5.1.2 Global Precision Medicine Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Precision Medicine Revenue
5.4 Global Precision Medicine Market Concentration Analysis
5.4.1 Global Precision Medicine Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Precision Medicine Revenue in 2024
5.5 Global Key Players of Precision Medicine Head office and Area Served
5.6 Global Key Players of Precision Medicine, Product and Application
5.7 Global Key Players of Precision Medicine, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Precision Medicine Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Precision Medicine Market Size by Type (2020-2025)
6.1.2.2 North America Precision Medicine Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Precision Medicine Market Size by Application (2020-2025)
6.1.3.2 North America Precision Medicine Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Precision Medicine Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Precision Medicine Market Size by Type (2020-2025)
6.2.2.2 Europe Precision Medicine Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Precision Medicine Market Size by Application (2020-2025)
6.2.3.2 Europe Precision Medicine Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Precision Medicine Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Precision Medicine Market Size by Type (2020-2025)
6.3.2.2 China Precision Medicine Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Precision Medicine Market Size by Application (2020-2025)
6.3.3.2 China Precision Medicine Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Precision Medicine Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Precision Medicine Market Size by Type (2020-2025)
6.4.2.2 Japan Precision Medicine Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Precision Medicine Market Size by Application (2020-2025)
6.4.3.2 Japan Precision Medicine Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Details
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Precision Medicine Introduction
7.1.4 Johnson & Johnson Revenue in Precision Medicine Business (2020-2025)
7.1.5 Johnson & Johnson Recent Development
7.2 Roche
7.2.1 Roche Company Details
7.2.2 Roche Business Overview
7.2.3 Roche Precision Medicine Introduction
7.2.4 Roche Revenue in Precision Medicine Business (2020-2025)
7.2.5 Roche Recent Development
7.3 Labcorp
7.3.1 Labcorp Company Details
7.3.2 Labcorp Business Overview
7.3.3 Labcorp Precision Medicine Introduction
7.3.4 Labcorp Revenue in Precision Medicine Business (2020-2025)
7.3.5 Labcorp Recent Development
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Details
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Precision Medicine Introduction
7.4.4 Abbott Laboratories Revenue in Precision Medicine Business (2020-2025)
7.4.5 Abbott Laboratories Recent Development
7.5 Novartis
7.5.1 Novartis Company Details
7.5.2 Novartis Business Overview
7.5.3 Novartis Precision Medicine Introduction
7.5.4 Novartis Revenue in Precision Medicine Business (2020-2025)
7.5.5 Novartis Recent Development
7.6 Illumina
7.6.1 Illumina Company Details
7.6.2 Illumina Business Overview
7.6.3 Illumina Precision Medicine Introduction
7.6.4 Illumina Revenue in Precision Medicine Business (2020-2025)
7.6.5 Illumina Recent Development
7.7 GE Healthcare
7.7.1 GE Healthcare Company Details
7.7.2 GE Healthcare Business Overview
7.7.3 GE Healthcare Precision Medicine Introduction
7.7.4 GE Healthcare Revenue in Precision Medicine Business (2020-2025)
7.7.5 GE Healthcare Recent Development
7.8 Intel Corporation
7.8.1 Intel Corporation Company Details
7.8.2 Intel Corporation Business Overview
7.8.3 Intel Corporation Precision Medicine Introduction
7.8.4 Intel Corporation Revenue in Precision Medicine Business (2020-2025)
7.8.5 Intel Corporation Recent Development
7.9 Biomrieux Sa
7.9.1 Biomrieux Sa Company Details
7.9.2 Biomrieux Sa Business Overview
7.9.3 Biomrieux Sa Precision Medicine Introduction
7.9.4 Biomrieux Sa Revenue in Precision Medicine Business (2020-2025)
7.9.5 Biomrieux Sa Recent Development
7.10 Cepheid
7.10.1 Cepheid Company Details
7.10.2 Cepheid Business Overview
7.10.3 Cepheid Precision Medicine Introduction
7.10.4 Cepheid Revenue in Precision Medicine Business (2020-2025)
7.10.5 Cepheid Recent Development
7.11 IBM
7.11.1 IBM Company Details
7.11.2 IBM Business Overview
7.11.3 IBM Precision Medicine Introduction
7.11.4 IBM Revenue in Precision Medicine Business (2020-2025)
7.11.5 IBM Recent Development
7.12 Qiagen
7.12.1 Qiagen Company Details
7.12.2 Qiagen Business Overview
7.12.3 Qiagen Precision Medicine Introduction
7.12.4 Qiagen Revenue in Precision Medicine Business (2020-2025)
7.12.5 Qiagen Recent Development
7.13 Thermo Fisher Scientific
7.13.1 Thermo Fisher Scientific Company Details
7.13.2 Thermo Fisher Scientific Business Overview
7.13.3 Thermo Fisher Scientific Precision Medicine Introduction
7.13.4 Thermo Fisher Scientific Revenue in Precision Medicine Business (2020-2025)
7.13.5 Thermo Fisher Scientific Recent Development
7.14 Randox Laboratories
7.14.1 Randox Laboratories Company Details
7.14.2 Randox Laboratories Business Overview
7.14.3 Randox Laboratories Precision Medicine Introduction
7.14.4 Randox Laboratories Revenue in Precision Medicine Business (2020-2025)
7.14.5 Randox Laboratories Recent Development
7.15 Almac Group
7.15.1 Almac Group Company Details
7.15.2 Almac Group Business Overview
7.15.3 Almac Group Precision Medicine Introduction
7.15.4 Almac Group Revenue in Precision Medicine Business (2020-2025)
7.15.5 Almac Group Recent Development
7.16 Healthcore
7.16.1 Healthcore Company Details
7.16.2 Healthcore Business Overview
7.16.3 Healthcore Precision Medicine Introduction
7.16.4 Healthcore Revenue in Precision Medicine Business (2020-2025)
7.16.5 Healthcore Recent Development
8 Precision Medicine Market Dynamics
8.1 Precision Medicine Industry Trends
8.2 Precision Medicine Market Drivers
8.3 Precision Medicine Market Challenges
8.4 Precision Medicine Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostics
1.2.3 Therapies
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Medicine Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Precision Medicine Revenue Market Share by Region (2020-2025)
2.4 Global Precision Medicine Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Precision Medicine Market Size and Prospective (2020-2031)
2.5.2 Europe Precision Medicine Market Size and Prospective (2020-2031)
2.5.3 China Precision Medicine Market Size and Prospective (2020-2031)
2.5.4 Japan Precision Medicine Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Precision Medicine Historic Market Size by Type (2020-2025)
3.2 Global Precision Medicine Forecasted Market Size by Type (2026-2031)
3.3 Different Types Precision Medicine Representative Players
4 Breakdown Data by Application
4.1 Global Precision Medicine Historic Market Size by Application (2020-2025)
4.2 Global Precision Medicine Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Precision Medicine Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Precision Medicine Players by Revenue (2020-2025)
5.1.2 Global Precision Medicine Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Precision Medicine Revenue
5.4 Global Precision Medicine Market Concentration Analysis
5.4.1 Global Precision Medicine Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Precision Medicine Revenue in 2024
5.5 Global Key Players of Precision Medicine Head office and Area Served
5.6 Global Key Players of Precision Medicine, Product and Application
5.7 Global Key Players of Precision Medicine, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Precision Medicine Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Precision Medicine Market Size by Type (2020-2025)
6.1.2.2 North America Precision Medicine Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Precision Medicine Market Size by Application (2020-2025)
6.1.3.2 North America Precision Medicine Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Precision Medicine Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Precision Medicine Market Size by Type (2020-2025)
6.2.2.2 Europe Precision Medicine Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Precision Medicine Market Size by Application (2020-2025)
6.2.3.2 Europe Precision Medicine Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Precision Medicine Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Precision Medicine Market Size by Type (2020-2025)
6.3.2.2 China Precision Medicine Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Precision Medicine Market Size by Application (2020-2025)
6.3.3.2 China Precision Medicine Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Precision Medicine Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Precision Medicine Market Size by Type (2020-2025)
6.4.2.2 Japan Precision Medicine Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Precision Medicine Market Size by Application (2020-2025)
6.4.3.2 Japan Precision Medicine Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Details
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Precision Medicine Introduction
7.1.4 Johnson & Johnson Revenue in Precision Medicine Business (2020-2025)
7.1.5 Johnson & Johnson Recent Development
7.2 Roche
7.2.1 Roche Company Details
7.2.2 Roche Business Overview
7.2.3 Roche Precision Medicine Introduction
7.2.4 Roche Revenue in Precision Medicine Business (2020-2025)
7.2.5 Roche Recent Development
7.3 Labcorp
7.3.1 Labcorp Company Details
7.3.2 Labcorp Business Overview
7.3.3 Labcorp Precision Medicine Introduction
7.3.4 Labcorp Revenue in Precision Medicine Business (2020-2025)
7.3.5 Labcorp Recent Development
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Details
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Precision Medicine Introduction
7.4.4 Abbott Laboratories Revenue in Precision Medicine Business (2020-2025)
7.4.5 Abbott Laboratories Recent Development
7.5 Novartis
7.5.1 Novartis Company Details
7.5.2 Novartis Business Overview
7.5.3 Novartis Precision Medicine Introduction
7.5.4 Novartis Revenue in Precision Medicine Business (2020-2025)
7.5.5 Novartis Recent Development
7.6 Illumina
7.6.1 Illumina Company Details
7.6.2 Illumina Business Overview
7.6.3 Illumina Precision Medicine Introduction
7.6.4 Illumina Revenue in Precision Medicine Business (2020-2025)
7.6.5 Illumina Recent Development
7.7 GE Healthcare
7.7.1 GE Healthcare Company Details
7.7.2 GE Healthcare Business Overview
7.7.3 GE Healthcare Precision Medicine Introduction
7.7.4 GE Healthcare Revenue in Precision Medicine Business (2020-2025)
7.7.5 GE Healthcare Recent Development
7.8 Intel Corporation
7.8.1 Intel Corporation Company Details
7.8.2 Intel Corporation Business Overview
7.8.3 Intel Corporation Precision Medicine Introduction
7.8.4 Intel Corporation Revenue in Precision Medicine Business (2020-2025)
7.8.5 Intel Corporation Recent Development
7.9 Biomrieux Sa
7.9.1 Biomrieux Sa Company Details
7.9.2 Biomrieux Sa Business Overview
7.9.3 Biomrieux Sa Precision Medicine Introduction
7.9.4 Biomrieux Sa Revenue in Precision Medicine Business (2020-2025)
7.9.5 Biomrieux Sa Recent Development
7.10 Cepheid
7.10.1 Cepheid Company Details
7.10.2 Cepheid Business Overview
7.10.3 Cepheid Precision Medicine Introduction
7.10.4 Cepheid Revenue in Precision Medicine Business (2020-2025)
7.10.5 Cepheid Recent Development
7.11 IBM
7.11.1 IBM Company Details
7.11.2 IBM Business Overview
7.11.3 IBM Precision Medicine Introduction
7.11.4 IBM Revenue in Precision Medicine Business (2020-2025)
7.11.5 IBM Recent Development
7.12 Qiagen
7.12.1 Qiagen Company Details
7.12.2 Qiagen Business Overview
7.12.3 Qiagen Precision Medicine Introduction
7.12.4 Qiagen Revenue in Precision Medicine Business (2020-2025)
7.12.5 Qiagen Recent Development
7.13 Thermo Fisher Scientific
7.13.1 Thermo Fisher Scientific Company Details
7.13.2 Thermo Fisher Scientific Business Overview
7.13.3 Thermo Fisher Scientific Precision Medicine Introduction
7.13.4 Thermo Fisher Scientific Revenue in Precision Medicine Business (2020-2025)
7.13.5 Thermo Fisher Scientific Recent Development
7.14 Randox Laboratories
7.14.1 Randox Laboratories Company Details
7.14.2 Randox Laboratories Business Overview
7.14.3 Randox Laboratories Precision Medicine Introduction
7.14.4 Randox Laboratories Revenue in Precision Medicine Business (2020-2025)
7.14.5 Randox Laboratories Recent Development
7.15 Almac Group
7.15.1 Almac Group Company Details
7.15.2 Almac Group Business Overview
7.15.3 Almac Group Precision Medicine Introduction
7.15.4 Almac Group Revenue in Precision Medicine Business (2020-2025)
7.15.5 Almac Group Recent Development
7.16 Healthcore
7.16.1 Healthcore Company Details
7.16.2 Healthcore Business Overview
7.16.3 Healthcore Precision Medicine Introduction
7.16.4 Healthcore Revenue in Precision Medicine Business (2020-2025)
7.16.5 Healthcore Recent Development
8 Precision Medicine Market Dynamics
8.1 Precision Medicine Industry Trends
8.2 Precision Medicine Market Drivers
8.3 Precision Medicine Market Challenges
8.4 Precision Medicine Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Precision Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Precision Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Precision Medicine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Precision Medicine Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Precision Medicine Revenue Share by Region (2020-2025)
Table 6. Global Precision Medicine Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Precision Medicine Revenue Share Forecast by Region (2026-2031)
Table 8. Global Precision Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Precision Medicine Revenue Market Share by Type (2020-2025)
Table 10. Global Precision Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Precision Medicine Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Precision Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Precision Medicine Revenue Market Share by Application (2020-2025)
Table 15. Global Precision Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Precision Medicine Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Precision Medicine Application
Table 18. Global Precision Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Precision Medicine Market Share by Players (2020-2025)
Table 20. Global Top Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Medicine as of 2024)
Table 21. Ranking of Global Top Precision Medicine Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Precision Medicine Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Precision Medicine, Headquarters and Area Served
Table 24. Global Key Players of Precision Medicine, Product and Application
Table 25. Global Key Players of Precision Medicine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Precision Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Precision Medicine Revenue Market Share by Company (2020-2025)
Table 29. North America Precision Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Precision Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Precision Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Precision Medicine Revenue Market Share by Company (2020-2025)
Table 33. Europe Precision Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Precision Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Precision Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Precision Medicine Revenue Market Share by Company (2020-2025)
Table 37. China Precision Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Precision Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Precision Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Precision Medicine Revenue Market Share by Company (2020-2025)
Table 41. Japan Precision Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Precision Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 43. Johnson & Johnson Company Details
Table 44. Johnson & Johnson Business Overview
Table 45. Johnson & Johnson Precision Medicine Product
Table 46. Johnson & Johnson Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 47. Johnson & Johnson Recent Development
Table 48. Roche Company Details
Table 49. Roche Business Overview
Table 50. Roche Precision Medicine Product
Table 51. Roche Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 52. Roche Recent Development
Table 53. Labcorp Company Details
Table 54. Labcorp Business Overview
Table 55. Labcorp Precision Medicine Product
Table 56. Labcorp Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 57. Labcorp Recent Development
Table 58. Abbott Laboratories Company Details
Table 59. Abbott Laboratories Business Overview
Table 60. Abbott Laboratories Precision Medicine Product
Table 61. Abbott Laboratories Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 62. Abbott Laboratories Recent Development
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Precision Medicine Product
Table 66. Novartis Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. Illumina Company Details
Table 69. Illumina Business Overview
Table 70. Illumina Precision Medicine Product
Table 71. Illumina Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 72. Illumina Recent Development
Table 73. GE Healthcare Company Details
Table 74. GE Healthcare Business Overview
Table 75. GE Healthcare Precision Medicine Product
Table 76. GE Healthcare Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 77. GE Healthcare Recent Development
Table 78. Intel Corporation Company Details
Table 79. Intel Corporation Business Overview
Table 80. Intel Corporation Precision Medicine Product
Table 81. Intel Corporation Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 82. Intel Corporation Recent Development
Table 83. Biomrieux Sa Company Details
Table 84. Biomrieux Sa Business Overview
Table 85. Biomrieux Sa Precision Medicine Product
Table 86. Biomrieux Sa Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 87. Biomrieux Sa Recent Development
Table 88. Cepheid Company Details
Table 89. Cepheid Business Overview
Table 90. Cepheid Precision Medicine Product
Table 91. Cepheid Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 92. Cepheid Recent Development
Table 93. IBM Company Details
Table 94. IBM Business Overview
Table 95. IBM Precision Medicine Product
Table 96. IBM Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 97. IBM Recent Development
Table 98. Qiagen Company Details
Table 99. Qiagen Business Overview
Table 100. Qiagen Precision Medicine Product
Table 101. Qiagen Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 102. Qiagen Recent Development
Table 103. Thermo Fisher Scientific Company Details
Table 104. Thermo Fisher Scientific Business Overview
Table 105. Thermo Fisher Scientific Precision Medicine Product
Table 106. Thermo Fisher Scientific Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 107. Thermo Fisher Scientific Recent Development
Table 108. Randox Laboratories Company Details
Table 109. Randox Laboratories Business Overview
Table 110. Randox Laboratories Precision Medicine Product
Table 111. Randox Laboratories Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 112. Randox Laboratories Recent Development
Table 113. Almac Group Company Details
Table 114. Almac Group Business Overview
Table 115. Almac Group Precision Medicine Product
Table 116. Almac Group Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 117. Almac Group Recent Development
Table 118. Healthcore Company Details
Table 119. Healthcore Business Overview
Table 120. Healthcore Precision Medicine Product
Table 121. Healthcore Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 122. Healthcore Recent Development
Table 123. Precision Medicine Market Trends
Table 124. Precision Medicine Market Drivers
Table 125. Precision Medicine Market Challenges
Table 126. Precision Medicine Market Restraints
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Precision Medicine Product Picture
Figure 2. Global Precision Medicine Market Share by Type: 2024 VS 2031
Figure 3. Diagnostics Features
Figure 4. Therapies Features
Figure 5. Global Precision Medicine Market Share by Application: 2024 VS 2031
Figure 6. Oncology
Figure 7. Neurosciences
Figure 8. Immunology
Figure 9. Respiratory
Figure 10. Others
Figure 11. Precision Medicine Report Years Considered
Figure 12. Global Precision Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Precision Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Precision Medicine Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Precision Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Precision Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Precision Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan Precision Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Precision Medicine Market Share by Players in 2024
Figure 20. Global Top Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Medicine as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Precision Medicine Revenue in 2024
Figure 22. North America Precision Medicine Market Share by Type (2020-2025)
Figure 23. North America Precision Medicine Market Share by Application (2020-2025)
Figure 24. Europe Precision Medicine Market Share by Type (2020-2025)
Figure 25. Europe Precision Medicine Market Share by Application (2020-2025)
Figure 26. China Precision Medicine Market Share by Type (2020-2025)
Figure 27. China Precision Medicine Market Share by Application (2020-2025)
Figure 28. Japan Precision Medicine Market Share by Type (2020-2025)
Figure 29. Japan Precision Medicine Market Share by Application (2020-2025)
Figure 30. Johnson & Johnson Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 31. Roche Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 32. Labcorp Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 33. Abbott Laboratories Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 34. Novartis Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 35. Illumina Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 36. GE Healthcare Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 37. Intel Corporation Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 38. Biomrieux Sa Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 39. Cepheid Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 40. IBM Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 41. Qiagen Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 42. Thermo Fisher Scientific Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 43. Randox Laboratories Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 44. Almac Group Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 45. Healthcore Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Table 1. Global Precision Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Precision Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Precision Medicine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Precision Medicine Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Precision Medicine Revenue Share by Region (2020-2025)
Table 6. Global Precision Medicine Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Precision Medicine Revenue Share Forecast by Region (2026-2031)
Table 8. Global Precision Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Precision Medicine Revenue Market Share by Type (2020-2025)
Table 10. Global Precision Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Precision Medicine Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Precision Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Precision Medicine Revenue Market Share by Application (2020-2025)
Table 15. Global Precision Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Precision Medicine Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Precision Medicine Application
Table 18. Global Precision Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Precision Medicine Market Share by Players (2020-2025)
Table 20. Global Top Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Medicine as of 2024)
Table 21. Ranking of Global Top Precision Medicine Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Precision Medicine Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Precision Medicine, Headquarters and Area Served
Table 24. Global Key Players of Precision Medicine, Product and Application
Table 25. Global Key Players of Precision Medicine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Precision Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Precision Medicine Revenue Market Share by Company (2020-2025)
Table 29. North America Precision Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Precision Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Precision Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Precision Medicine Revenue Market Share by Company (2020-2025)
Table 33. Europe Precision Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Precision Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Precision Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Precision Medicine Revenue Market Share by Company (2020-2025)
Table 37. China Precision Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Precision Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Precision Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Precision Medicine Revenue Market Share by Company (2020-2025)
Table 41. Japan Precision Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Precision Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 43. Johnson & Johnson Company Details
Table 44. Johnson & Johnson Business Overview
Table 45. Johnson & Johnson Precision Medicine Product
Table 46. Johnson & Johnson Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 47. Johnson & Johnson Recent Development
Table 48. Roche Company Details
Table 49. Roche Business Overview
Table 50. Roche Precision Medicine Product
Table 51. Roche Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 52. Roche Recent Development
Table 53. Labcorp Company Details
Table 54. Labcorp Business Overview
Table 55. Labcorp Precision Medicine Product
Table 56. Labcorp Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 57. Labcorp Recent Development
Table 58. Abbott Laboratories Company Details
Table 59. Abbott Laboratories Business Overview
Table 60. Abbott Laboratories Precision Medicine Product
Table 61. Abbott Laboratories Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 62. Abbott Laboratories Recent Development
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Precision Medicine Product
Table 66. Novartis Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. Illumina Company Details
Table 69. Illumina Business Overview
Table 70. Illumina Precision Medicine Product
Table 71. Illumina Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 72. Illumina Recent Development
Table 73. GE Healthcare Company Details
Table 74. GE Healthcare Business Overview
Table 75. GE Healthcare Precision Medicine Product
Table 76. GE Healthcare Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 77. GE Healthcare Recent Development
Table 78. Intel Corporation Company Details
Table 79. Intel Corporation Business Overview
Table 80. Intel Corporation Precision Medicine Product
Table 81. Intel Corporation Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 82. Intel Corporation Recent Development
Table 83. Biomrieux Sa Company Details
Table 84. Biomrieux Sa Business Overview
Table 85. Biomrieux Sa Precision Medicine Product
Table 86. Biomrieux Sa Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 87. Biomrieux Sa Recent Development
Table 88. Cepheid Company Details
Table 89. Cepheid Business Overview
Table 90. Cepheid Precision Medicine Product
Table 91. Cepheid Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 92. Cepheid Recent Development
Table 93. IBM Company Details
Table 94. IBM Business Overview
Table 95. IBM Precision Medicine Product
Table 96. IBM Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 97. IBM Recent Development
Table 98. Qiagen Company Details
Table 99. Qiagen Business Overview
Table 100. Qiagen Precision Medicine Product
Table 101. Qiagen Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 102. Qiagen Recent Development
Table 103. Thermo Fisher Scientific Company Details
Table 104. Thermo Fisher Scientific Business Overview
Table 105. Thermo Fisher Scientific Precision Medicine Product
Table 106. Thermo Fisher Scientific Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 107. Thermo Fisher Scientific Recent Development
Table 108. Randox Laboratories Company Details
Table 109. Randox Laboratories Business Overview
Table 110. Randox Laboratories Precision Medicine Product
Table 111. Randox Laboratories Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 112. Randox Laboratories Recent Development
Table 113. Almac Group Company Details
Table 114. Almac Group Business Overview
Table 115. Almac Group Precision Medicine Product
Table 116. Almac Group Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 117. Almac Group Recent Development
Table 118. Healthcore Company Details
Table 119. Healthcore Business Overview
Table 120. Healthcore Precision Medicine Product
Table 121. Healthcore Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 122. Healthcore Recent Development
Table 123. Precision Medicine Market Trends
Table 124. Precision Medicine Market Drivers
Table 125. Precision Medicine Market Challenges
Table 126. Precision Medicine Market Restraints
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Precision Medicine Product Picture
Figure 2. Global Precision Medicine Market Share by Type: 2024 VS 2031
Figure 3. Diagnostics Features
Figure 4. Therapies Features
Figure 5. Global Precision Medicine Market Share by Application: 2024 VS 2031
Figure 6. Oncology
Figure 7. Neurosciences
Figure 8. Immunology
Figure 9. Respiratory
Figure 10. Others
Figure 11. Precision Medicine Report Years Considered
Figure 12. Global Precision Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Precision Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Precision Medicine Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Precision Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Precision Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Precision Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan Precision Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Precision Medicine Market Share by Players in 2024
Figure 20. Global Top Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Medicine as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Precision Medicine Revenue in 2024
Figure 22. North America Precision Medicine Market Share by Type (2020-2025)
Figure 23. North America Precision Medicine Market Share by Application (2020-2025)
Figure 24. Europe Precision Medicine Market Share by Type (2020-2025)
Figure 25. Europe Precision Medicine Market Share by Application (2020-2025)
Figure 26. China Precision Medicine Market Share by Type (2020-2025)
Figure 27. China Precision Medicine Market Share by Application (2020-2025)
Figure 28. Japan Precision Medicine Market Share by Type (2020-2025)
Figure 29. Japan Precision Medicine Market Share by Application (2020-2025)
Figure 30. Johnson & Johnson Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 31. Roche Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 32. Labcorp Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 33. Abbott Laboratories Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 34. Novartis Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 35. Illumina Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 36. GE Healthcare Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 37. Intel Corporation Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 38. Biomrieux Sa Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 39. Cepheid Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 40. IBM Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 41. Qiagen Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 42. Thermo Fisher Scientific Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 43. Randox Laboratories Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 44. Almac Group Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 45. Healthcore Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232